micronet ├── __init__.py ├── base_module │ ├── __init__.py │ └── op.py ├── compression │ ├── README.md ...
Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...
Abstract: A low-power 12-bit successive approximation register (SAR) analog-to-digital converter (ADC) with split-capacitor, nonbinary-weighted, and multiple-least-significant-bit (LSB)-redundant ...
In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...
Abstract: Cooperative co-evolution (CC) is an efficient and practical evolutionary framework for solving large-scale optimization problems. The performance of CC is affected by the variable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback